Document Detail

Cellular immune responses in multiple sclerosis patients treated with interferon-beta.
MedLine Citation:
PMID:  23379429     Owner:  NLM     Status:  MEDLINE    
We investigated cellular immune responses at baseline in peripheral blood mononuclear cells (PBMC) of patients with multiple sclerosis (MS) treated with interferon (IFN)-β and classified into responders and non-responders according to clinical response criteria. Levels for IFN-γ, interleukin (IL)-17A, IL-17F, IL-10 and IL-4 were determined in activated PBMC of 10 responders, 10 non-responders and 10 healthy controls by cytometric bead arrays. Cytokine levels in cell culture supernatants were similar between responders and non-responders, and comparable to those obtained in healthy controls. These findings do not support differential cellular immune responses in PBMC at baseline between IFN-β responders and non-responders.
M F Bustamante; J Rio; Z Castro; A Sánchez; X Montalban; M Comabella
Related Documents :
15949689 - Can beta-carotene regulate cell growth by a redox mechanism? an answer from cultured ce...
23994589 - Total expression of hla-g and tlr-9 in chronic lymphocytic leukemia patients.
23708099 - Immune-pineal axis: nuclear factor κb (nf-kb) mediates the shift in the melatonin sour...
25107979 - Distinct immunomodulation of bone marrow-derived dendritic cells responses to lactobaci...
24752969 - Zip1 and zinc inhibits fluoride-induced apoptosis in mc3t3-e1 cells.
25088199 - Lineage-specific runx3 hypomethylation marks the preneoplastic immune component of gast...
11570579 - Thymidine-dependent attenuation of the mitochondrial apoptotic pathway in adenosine-ind...
8165619 - Expression and localization of tissue factor-based procoagulant activity (pca) in pigeo...
19133139 - Absence of the complement regulatory molecule cd59a leads to exacerbated neuropathology...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical and experimental immunology     Volume:  171     ISSN:  1365-2249     ISO Abbreviation:  Clin. Exp. Immunol.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-05     Completed Date:  2013-04-02     Revised Date:  2014-03-06    
Medline Journal Info:
Nlm Unique ID:  0057202     Medline TA:  Clin Exp Immunol     Country:  England    
Other Details:
Languages:  eng     Pagination:  243-6     Citation Subset:  IM    
Copyright Information:
© 2012 British Society for Immunology.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Case-Control Studies
Cytokines / analysis
Interferon-beta / immunology,  therapeutic use*
Multiple Sclerosis / drug therapy*,  immunology*
Reg. No./Substance:
0/Cytokines; 77238-31-4/Interferon-beta

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper typ...
Next Document:  Characteristics of in-vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titr...